News Results
There are 984,458 News Results
Jun 13, 2017
NEW YORK, June 14, 2017 /PRNewswire/ -- New York Cruise Lines , parent company of iconic Circle Line Sightseeing Cruises, is adding a new fleet to their exemplary roster with...
Jun 21, 2017
MUNICH, June 22, 2017 /PRNewswire/ -- IBM (NYSE: IBM ) today announced sweeping advances to its data governance and data science initiatives designed to help developers and analysts tap into...
Aug 22, 2017
OSLO, Norway, August 23, 2017 /PRNewswire/ -- Nordic Nanovector (OSE: NANO) publiserer i dag resultater for andre kvartal og første halvar 2017. Selskapets ledelse vil gi en presentasjon av resultatene...
Aug 22, 2017
NEW YORK, Aug. 23, 2017 /PRNewswire/ -- Below are experts from the ProfNet network who are available to discuss timely issues in your coverage area. You can also submit a...
Sep 11, 2017
SAN FRANCISCO, Sept. 12, 2017 /PRNewswire/ -- Salesforce.org, the philanthropic arm of Salesforce (NYSE: CRM), announced today it will donate $12.2 million to San Francisco Unified School District (SFUSD) and...
Oct 8, 2017
BASEL, Switzerland, October 10, 2017 /PRNewswire/ -- Mundipharma EDO GmbH (EDO) has begun a US Phase 1/2 clinical study for tinostamustine (EDO-S101) in patients with advanced solid tumors at Stanford...
Oct 9, 2017
DALLAS, Oct. 10, 2017 /PRNewswire/ -- Desirae Vazquez knew there had to be a better way to manage medical records. Every month, her ASC -- Sequoia Surgery Center in Visalia,...
Oct 15, 2017
SAN FRANCISCO and BOSTON, Oct. 16, 2017 /PRNewswire-USNewswire/ -- The Parker Institute for Cancer Immunotherapy today announced that researchers at Dana-Farber Cancer Institute have joined its network. Dana-Farber is a...
Oct 15, 2017
NEW YORK, Oct. 16, 2017 /PRNewswire-USNewswire/ -- Two renowned Parkinson's disease and movement disorders physician-researchers have been appointed co-executive directors of the Marlene and Paolo Fresco Institute for Parkinson's and...
Oct 18, 2017
NEW YORK and ANN ARBOR, Mich., Oct. 19, 2017 /PRNewswire/ -- Lycera Corp., a privately held biopharmaceutical company developing breakthrough immune modulatory medicines, today announced the initiation of the Phase...
